Relations between Effects and Structure of Small Bicyclic Molecules on the Complex Model System Saccharomyces cerevisiae

The development of compounds able to modify biological functions largely took advantage of parallel synthesis to generate a broad chemical variance of compounds to be tested for the desired effect(s). The budding yeast Saccharomyces cerevisiae is a model for pharmacological studies since a long time as it represents a relatively simple system to explore the relations among chemical variance and bioactivity. To identify relations between the chemical features of the molecules and their activity, we delved into the effects of a library of small compounds on the viability of a set of S. cerevisiae strains. Thanks to the high degree of chemical diversity of the tested compounds and to the measured effect on the yeast growth rate, we were able to scale-down the chemical library and to gain information on the most effective structures at the substituent level. Our results represent a valuable source for the selection, rational design, and optimization of bioactive compounds.

[1]  K. Mikkelsen,et al.  Polarizability of molecular clusters as calculated by a dipole interaction model , 2002 .

[2]  P. Clemons,et al.  Target identification and mechanism of action in chemical biology and drug discovery. , 2013, Nature chemical biology.

[3]  A. Pupi,et al.  3-Aza-6,8-dioxabicyclo[3.2.1]octanes as new enantiopure heteroatom-rich tropane-like ligands of human dopamine transporter. , 2006, Bioorganic & medicinal chemistry.

[4]  Feng Cong,et al.  Chemical genetics-based target identification in drug discovery. , 2012, Annual review of pharmacology and toxicology.

[5]  Anne-Béatrice Dufour,et al.  The ade4 Package: Implementing the Duality Diagram for Ecologists , 2007 .

[6]  A. Goffeau,et al.  Identification and Characterization of SNQ2, a New Multidrug ATP Binding Cassette Transporter of the Yeast Plasma Membrane (*) , 1995, The Journal of Biological Chemistry.

[7]  D C Swinney,et al.  Phenotypic vs. Target‐Based Drug Discovery for First‐in‐Class Medicines , 2013, Clinical pharmacology and therapeutics.

[8]  Andreas Bender,et al.  Diversity-oriented synthesis; a spectrum of approaches and results. , 2008, Organic & biomolecular chemistry.

[9]  P. Filzmoser,et al.  Redundancy analysis for characterizing the correlation between groups of variables - Applied to molecular descriptors , 2012 .

[10]  J. Bajorath Structure–Activity Relationship Data Analysis: Activity Landscapes and Activity Cliffs , 2013 .

[11]  M. Ghannoum,et al.  Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance , 1999, Clinical Microbiology Reviews.

[12]  D. Potenza,et al.  Synthesis and conformational analysis of small peptides containing 6-endo-BT(t)L scaffolds as reverse turn mimetics. , 2002, The Journal of organic chemistry.

[13]  Corey Nislow,et al.  Yeast chemical genomics and drug discovery: an update. , 2008, Trends in pharmacological sciences.

[14]  A. Trabocchi,et al.  Synthesis and Reactivity of Bicycles Derived from Tartaric Acid and α-Amino Acids: A Novel Class of Conformationally Constrained Dipeptide Isosteres Based upon Enantiopure 3-Aza-6,8-dioxabicyclo[3.2.1]octane-7-carboxylic Acid , 1999 .

[15]  Warren R. J. D. Galloway,et al.  The Basics of Diversity‐Oriented Synthesis , 2013 .

[16]  A. Rincón,et al.  Increased biomass production of industrial bakers' yeasts by overexpression of Hap4 gene. , 2010, International journal of food microbiology.

[17]  J. Mccusker,et al.  Development of Saccharomyces Cerevisiae as a Model Pathogen: a System for the Genetic Identification of Gene Products Required for Survival in the Mammalian Host Environment Tion and Therefore Simultaneously Exposed to the Same , 2001 .

[18]  A. Trabocchi,et al.  A solid-phase approach towards the development of 3-aza-6,8-dioxabicyclo[3.2.1]octane scaffolds , 2004, Molecular Diversity.

[19]  A. Trabocchi,et al.  Structural diversity of bicyclic amino acids , 2007, Amino Acids.

[20]  William N. Venables,et al.  Modern Applied Statistics with S , 2010 .

[21]  D. Swinney,et al.  How were new medicines discovered? , 2011, Nature Reviews Drug Discovery.

[22]  C. Kappe,et al.  Parallel synthesis of an amide library based on the 6,8-dioxa-3-azabicyclo[3.2.1]octane scaffold by direct aminolysis of methyl esters. , 2007, Journal of combinatorial chemistry.

[23]  D. Cavalieri,et al.  A Systems Biology Approach to Dissection of the Effects of Small Bicyclic Peptidomimetics on a Panel of Saccharomyces cerevisiae Mutants* , 2010, The Journal of Biological Chemistry.

[24]  G. Schneider,et al.  The State of the Art of Chemical Biology , 2009, Chembiochem : a European journal of chemical biology.

[25]  K. Kuchler,et al.  Fungal ABC proteins: pleiotropic drug resistance, stress response and cellular detoxification. , 2001, Research in microbiology.

[26]  K. Śmietana,et al.  Trends in clinical success rates , 2016, Nature Reviews Drug Discovery.

[27]  S. Haggarty,et al.  Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Charles Brenner,et al.  Chemical genomics in yeast , 2004, Genome Biology.